Published in Am J Cardiol on December 15, 2002
Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull (2004) 8.52
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry (2008) 3.08
Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry (2008) 2.82
Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry (2007) 2.44
Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav Immun (2007) 2.18
Maternal warmth buffers the effects of low early-life socioeconomic status on pro-inflammatory signaling in adulthood. Mol Psychiatry (2010) 1.90
A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun (2009) 1.88
Does depression predict coronary heart disease and cerebrovascular disease equally well? The Health and Social Support Prospective Cohort Study. Int J Epidemiol (2010) 1.84
Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry (2008) 1.70
Psychological distress and C-reactive protein: do health behaviours and pathophysiological factors modify the association? Eur Arch Psychiatry Clin Neurosci (2010) 1.60
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience (2013) 1.55
Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr (2007) 1.45
Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun (2007) 1.42
Positive and negative affect and risk of coronary heart disease: Whitehall II prospective cohort study. BMJ (2008) 1.42
Socioeconomic and psychosocial predictors of interleukin-6 in the MIDUS national sample. Health Psychol (2010) 1.39
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38
A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol (2007) 1.36
Neural alterations and depressive symptoms in obstructive sleep apnea patients. Sleep (2008) 1.34
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol (2009) 1.28
Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry (2008) 1.27
Depressive symptoms are associated with elevated serum proinflammatory cytokines among pregnant women. Brain Behav Immun (2009) 1.27
Depressive symptoms and increased visceral fat in middle-aged women. Psychosom Med (2009) 1.27
Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom Med (2010) 1.23
Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol Psychiatry (2006) 1.13
Diseases of poverty and lifestyle, well-being and human development. Mens Sana Monogr (2008) 1.10
Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res (2007) 1.09
Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin North Am (2009) 1.08
Depression and heart rate variability in patients with coronary heart disease. Cleve Clin J Med (2009) 1.07
Symptoms of depression and impaired endothelial function in healthy adolescent women. J Behav Med (2008) 1.07
Depression and cardiovascular comorbidity. Dialogues Clin Neurosci (2007) 1.04
Depressive symptoms enhance stress-induced inflammatory responses. Brain Behav Immun (2012) 1.04
Psychoneuroimmunology in pregnancy: immune pathways linking stress with maternal health, adverse birth outcomes, and fetal development. Neurosci Biobehav Rev (2011) 1.04
Early environments and the ecology of inflammation. Proc Natl Acad Sci U S A (2012) 1.03
Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study. Psychosom Med (2008) 1.01
Reproductive age-related changes in the blood brain barrier: expression of IgG and tight junction proteins. Microvasc Res (2009) 0.99
The association between depression and leptin is mediated by adiposity. Psychosom Med (2012) 0.99
Lifetime exposure to traumatic psychological stress is associated with elevated inflammation in the Heart and Soul Study. Brain Behav Immun (2012) 0.96
Mediation and modification of the association between hopelessness, hostility, and progression of carotid atherosclerosis. J Behav Med (2005) 0.95
Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med (2003) 0.92
Physical functioning among mid-life women: associations with trajectory of depressive symptoms. Soc Sci Med (2010) 0.90
Toward an anti-inflammatory strategy for depression. Front Behav Neurosci (2011) 0.90
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin Neurosci (2007) 0.88
Association between depression and coronary artery calcification in women with systemic lupus erythematosus. Rheumatology (Oxford) (2009) 0.88
Depressive symptoms are associated with visceral adiposity in a community-based sample of middle-aged women and men. Obesity (Silver Spring) (2013) 0.87
Effects of stress and depression on inflammatory immune parameters in pregnancy. Am J Obstet Gynecol (2014) 0.87
Excess risk of chronic physical conditions associated with depression and anxiety. BMC Psychiatry (2014) 0.87
Hostility, anger, and depression predict increases in C3 over a 10-year period. Brain Behav Immun (2007) 0.87
The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study. Eur Arch Psychiatry Clin Neurosci (2011) 0.86
Depressive symptoms and the risk of ischemic stroke in the elderly--influence of age and sex. PLoS One (2012) 0.86
HIV infection and drugs of abuse: role of acute phase proteins. J Neuroinflammation (2013) 0.85
Systemic inflammation is associated with ovarian follicular dynamics during the human menstrual cycle. PLoS One (2013) 0.85
Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study. J Neurovirol (2016) 0.84
Inflammatory cytokine-associated depression. Brain Res (2014) 0.84
Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease? J Neural Transm (Vienna) (2010) 0.84
Depression and incident diabetic retinopathy: a prospective cohort study. Gen Hosp Psychiatry (2011) 0.83
Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int (2011) 0.83
Increased Serum Cu/Zn SOD in Individuals with Clinical Depression Normalizes After Zinc and Anti-oxidant Therapy. Nutr Metab Insights (2010) 0.83
Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Med (2013) 0.83
Inflammation in depression: is adiposity a cause? Dialogues Clin Neurosci (2011) 0.83
Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study. Horm Metab Res (2009) 0.82
Current understanding of the bi-directional relationship of major depression with inflammation. Biol Mood Anxiety Disord (2012) 0.82
Causal inference regarding infectious aetiology of chronic conditions: a systematic review. PLoS One (2013) 0.82
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine. Neuropsychopharmacology (2016) 0.81
Common genetic factors for depression and cardiovascular disease. Dialogues Clin Neurosci (2007) 0.81
Is chronic inflammation a possible cause of obesity-related depression? Mediators Inflamm (2009) 0.81
The pro-inflammatory profile of depressed patients is (partly) related to obesity. J Psychiatr Res (2015) 0.80
Depression and the Link with Cardiovascular Disease. Front Psychiatry (2016) 0.80
The impact of mood and anxiety disorders on incident hypertension at one year. Int J Hypertens (2014) 0.80
Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study. Psychosom Med (2015) 0.80
Patterns and associates of cognitive function, psychosocial wellbeing and health in the Lothian Birth Cohort 1936. BMC Geriatr (2014) 0.80
Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression. J Pharmacol Pharmacother (2011) 0.80
Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes? Child Psychiatry Hum Dev (2015) 0.79
Neuropathology of mood disorders: do we see the stigmata of inflammation? Transl Psychiatry (2016) 0.78
Fish consumption and polyunsaturated fatty acids in relation to psychological distress. Int J Epidemiol (2010) 0.78
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome. BMC Cardiovasc Disord (2015) 0.78
Identification of hypertensive patients with dominant affective temperaments might improve the psychopathological and cardiovascular risk stratification: a pilot, case-control study. Ann Gen Psychiatry (2015) 0.78
Genetic biomarkers of depression. Indian J Hum Genet (2012) 0.77
Sex, psychosocial factors, and reported symptoms influence referral for esophagogastroduodenoscopy and biopsy results in children with chronic abdominal pain. J Pediatr Gastroenterol Nutr (2008) 0.77
Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome. Am J Cardiol (2010) 0.77
Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review. Int J Mol Sci (2016) 0.76
Depressive symptoms in a general population: associations with obesity, inflammation, and blood pressure. Cardiol Res Pract (2011) 0.76
Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma. Rev Bras Psiquiatr (2010) 0.76
Mild depressive symptoms are associated with elevated C-reactive protein and proinflammatory cytokine levels during early to midgestation: a prospective pilot study. J Womens Health (Larchmt) (2012) 0.76
Psychosocial stress as a risk factor for sepsis: a population-based cohort study. Psychosom Med (2015) 0.76
Genome-Wide Profiling of RNA from Dried Blood Spots: Convergence with Bioinformatic Results Derived from Whole Venous Blood and Peripheral Blood Mononuclear Cells. Biodemography Soc Biol (2016) 0.76
The protective effects of resveratrol on social stress-induced cytokine release and depressive-like behavior. Brain Behav Immun (2016) 0.76
Visceral Fat Accumulation, Insulin Resistance, and Elevated Depressive Symptoms in Middle-Aged Japanese Men. PLoS One (2016) 0.76
Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients. Expert Opin Pharmacother (2010) 0.75
Depression and Progression of Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) (2016) 0.75
Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression. Curr Neuropharmacol (2015) 0.75
Idiopathic urethritis in young men in the United States: prevalence and comparison to infections with known sexually transmitted pathogens. J Adolesc Health (2009) 0.75
Role of Heart and its Diseases in the Etiology of Depression According to Avicenna's Point of View and its Comparison with Views of Classic Medicine. Int J Prev Med (2015) 0.75
Early death after emergency department discharge in patients with psychiatric illness. Am J Emerg Med (2016) 0.75
Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress. Neurobiol Stress (2016) 0.75
Genetic and environmental determinants of population variation in interleukin-6, its soluble receptor and C-reactive protein: insights from identical and fraternal twins. Brain Behav Immun (2015) 0.75
Neuropsychiatric symptoms in patients with aortic aneurysms. PLoS One (2011) 0.75
Adiposity is inversely associated with hippocampal volume in African Americans and European Americans with diabetes. J Diabetes Complications (2016) 0.75
Association of depression with common carotid artery intima media thickness and augmentation index in a large Urban South Indian population- The Chennai Urban Rural Epidemiology Study (CURES - 138). Indian J Endocrinol Metab (2015) 0.75
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci (2006) 4.25
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med (2003) 3.57
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41
Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res (2002) 3.27
Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87
Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol (2007) 2.57
Brain-immune communication pathways. Brain Behav Immun (2007) 2.50
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50
Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry (2009) 2.49
Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res (2002) 2.41
Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med (2005) 2.36
Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation (2002) 2.32
Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med (2011) 2.29
The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med (2002) 2.22
Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide. Brain Behav Immun (2005) 2.18
Strategies to advance translational research into brain barriers. Lancet Neurol (2008) 2.16
Death takes a raincheck. Psychosom Med (2004) 2.10
Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med (2002) 2.02
Effects of leptin on memory processing. Peptides (2005) 1.97
Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier. Proc Natl Acad Sci U S A (2004) 1.97
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96
Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry (2003) 1.96
Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology (2008) 1.94
Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol (2003) 1.82
Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA (2009) 1.79
Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med (2003) 1.75
Depression in patients with coronary heart disease. Am J Med (2008) 1.73
The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom (2009) 1.70
Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med (2005) 1.70
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem (2003) 1.67
History of depression and survival after acute myocardial infarction. Psychosom Med (2009) 1.65
Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64
Medical disorders among patients admitted to a public-sector psychiatric inpatient unit. Psychiatr Serv (2002) 1.61
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun (2003) 1.60
A simple method to identify sleep apnea using Holter recordings. J Cardiovasc Electrophysiol (2003) 1.56
The effects of animal-assisted therapy on loneliness in an elderly population in long-term care facilities. J Gerontol A Biol Sci Med Sci (2002) 1.51
Peroxisome proliferator-activated receptor-gamma-mediated positive energy balance in the rat is associated with reduced sympathetic drive to adipose tissues and thyroid status. Endocrinology (2008) 1.47
Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab (2013) 1.45
Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry (2006) 1.45
Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol (2005) 1.43
The Great Debate, revisited. Psychosom Med (2006) 1.42
Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. J Cardiopulm Rehabil (2003) 1.41
Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry (2009) 1.40
HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res (2005) 1.39
Prescription opioid analgesics increase the risk of depression. J Gen Intern Med (2013) 1.37
Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology (2002) 1.36
Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides (2007) 1.35
Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J Biol Chem (2003) 1.34
Telephone-based coping skills training for patients awaiting lung transplantation. J Consult Clin Psychol (2006) 1.33
Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun (2009) 1.32
Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients. Am Heart J (2010) 1.27
Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes (2006) 1.27
Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. Bioconjug Chem (2005) 1.26
Animal-assisted therapy and loneliness in nursing homes: use of robotic versus living dogs. J Am Med Dir Assoc (2008) 1.23
Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry (2006) 1.21
Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. Am Heart J (2003) 1.19
Epinephrine enhances lysosomal enzyme delivery across the blood brain barrier by up-regulation of the mannose 6-phosphate receptor. Proc Natl Acad Sci U S A (2007) 1.18
Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab (2009) 1.17
Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis (2009) 1.17
Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J Neuroinflammation (2011) 1.16
Depression and coronary heart disease in women with diabetes. Psychosom Med (2003) 1.15
Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav Immun (2011) 1.15
Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse. Mol Ther (2008) 1.14
Depression and obstructive sleep apnea in patients with coronary heart disease. Psychosom Med (2006) 1.13
A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Exp Neurol (2006) 1.12
Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice. Endocrinology (2011) 1.11
Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Am Heart J (2006) 1.11
Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide. FASEB J (2002) 1.11
Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial. Psychother Psychosom (2007) 1.10
Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom Med (2004) 1.10
Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc (2004) 1.10
Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflammation (2012) 1.09
Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res (2007) 1.09
Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. Am Heart J (2003) 1.09
Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. J Pharmacol Exp Ther (2003) 1.08
Psychiatric disorder and quality of life in patients awaiting lung transplantation. Chest (2003) 1.07
Effects of orexin-A on memory processing. Peptides (2002) 1.07
Depression and heart rate variability in patients with coronary heart disease. Cleve Clin J Med (2009) 1.07
Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure. Psychosom Med (2007) 1.07
N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res (2009) 1.06